Key result
Perioperative beta-blockers in non-cardiac surgery may reduce myocardial infarction but increase the risk of stroke, hypotension, and bradycardia, lacking strong evidence for routine new initiation.
Why the study?
Do beta-blockers affect perioperative arrhythmia, myocardial infarction, stroke, and mortality in patients undergoing non-cardiac surgery?
Do beta-blockers affect perioperative arrhythmia, myocardial infarction, stroke, and mortality in patients undergoing non-cardiac surgery?
This narrative review summarizes current guidelines and large trials regarding the initiation, continuation, and dosage of beta-blockers in patients undergoing non-cardiac surgery.
Cautions against routine de novo beta-blocker initiation before non-card.
: Several trials have evaluated the role of treatment with beta-blockers in patients undergoing non-cardiac surgery. Debates are when and which agent and dosage to initiate and when and how to continue or discontinue. In addition, effects on perioperative arrhythmia, myocardial infarction, stroke, and mortality were studied. Herein we have tried to review the most common guidelines and large trials on the aforementioned issues.
No takes yet. Share an insight, caveat, or question.
Sherafati et al. (2017) conducted a review in Patients undergoing non-cardiac surgery. Beta-blockers was evaluated. Perioperative beta-blockers in non-cardiac surgery may reduce myocardial infarction but increase the risk of stroke, hypotension, and bradycardia, lacking strong evidence for routine new initiation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: